Heat Shock Protein 90 as a Drug Target against Protozoan Infections
Open Access
- 1 December 2010
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (49) , 37964-37975
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Virtual prototyping study shows increased ATPase activity of Hsp90 to be the key determinant of cancer phenotypeSystems and Synthetic Biology, 2009
- The Charged Linker Region Is an Important Regulator of Hsp90 FunctionJournal of Biological Chemistry, 2009
- Role of Acetylation and Extracellular Location of Heat Shock Protein 90α in Tumor Cell InvasionCancer Research, 2008
- p23/Sba1p Protects against Hsp90 Inhibitors Independently of Its Intrinsic Chaperone ActivityMolecular and Cellular Biology, 2008
- Multiple Conformations of E. coli Hsp90 in Solution: Insights into the Conformational Dynamics of Hsp90Structure, 2008
- Mechanistic Studies on Hsp90 Inhibition by Ansamycin DerivativesJournal of Molecular Biology, 2007
- A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analoguesProceedings of the National Academy of Sciences, 2006
- Toxoplasma gondii Hsp90 is a Potential Drug Target Whose Expression and Subcellular Localization are Developmentally RegulatedJournal of Molecular Biology, 2005
- Independent ATPase Activity of Hsp90 Subunits Creates a Flexible Assembly PlatformJournal of Molecular Biology, 2004
- Hsp90 as a capacitor of phenotypic variationNature, 2002